Nonetheless, the PK/PD model developed in this study may be useful as such in future studies for assessing the activity of not only PDE inhibitors but also other anti-inflammatory and immunomodulatory compounds as potential drug candidates for the treatment of AIH. Here, ALDH7A1 is linked to autoimmune hepatitis.